CREB UPC participated in the digital Workshop of the Interuniversity PhD Program in Bioinformatics, a session where the students defended their thesis in three minutes, but also had an opportunity to learn from other voices in the industry. CREB UPC also introduced Xartec Salut to the dozens of students. Made up of 47 research groups from Catalonia, Xartec Salut aims to be an ecosystem to catalyse tech transfer in the healthtech industry. “One of our main goals is to foster the exchange of knowledge and technology transfer between the different agents, in order to have a greater economic and social impact”, claimed Sergio San Agustín, innovation promoter at Xartec Salut.
The MITEF Spain Jury has reached this decision considering their business model, technology, market potential and evolution, and the team itself.They have developed a technology that is capable of sequencing RNA, from a small blood sample, and associating the expression of genes in more than 320 metabolic pathways that act as biomarkers of the parameters of the individual's body, analyzing all those variations that are out of the ordinary to improve and prevent health problems.
1 ”Use of artificial intelligence and biology systems for the diagnosis and personalized risk assessment for inherited kidney disease, focusing on Alport syndrome” 2 “ArmTracker: A portable system for assessing motor function of the upper extremities during daily life for patients with Duchenne muscular dystrophy and spinal muscular atrophy” 3 “Development of personalized treatments in rare genetic diseases causing pediatric parkinsonism” Congratulations to our researchers and partners and of course, congratulations to the rest of the projects.
Share4Rare is a system in which patients with a diagnosis can interact, communicate, and share knowledge with other users sharing the same diagnosis. It will also bridge the user to the most relevant patient organizations according to its disease. The question for Share4Rare is whether the platform could benefit the undiagnosed populations by exploiting its AI-based design. This design aims to foster the knowledge on rare diseases through collaborative intelligence built on equity principles.
TECNIO is the accreditation granted by the Generalitat of Catalonia through ACCIÓ to identify and give visibility to the technology developers of the R&D&I system of Catalonia. This should help to encourage the activity of the Catalan technology market among technology generators, buyers, facilitators, and other collaborators in the process, such as consultants and business schools.